Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Regeneron Takes Full Libtayo Rights As March Into Oncology Progresses
Jun 02 2022
•
By
Jessica Merrill
Regeneron will go it alone with Libtayo • Source: Shutterstock
More from Anticancer
More from Therapeutic Category